Biotech
Cardiff Oncology's $60M Cash Reserve Gives Five Quarters Before Funding Crisis
ViaNews Editorial Team•
#Venture Capital
46 articles
Healthcare
Biotech Funding Drought Puts $300M Ophthalmology Drug at Risk of Capital Collapse
ViaNews Editorial Team•
Private Markets
Venture Capital LPs Face 30-60% Haircuts on Exits, Shift to Credit Solutions
ViaNews Editorial Team•
Business
AI Startups Pull $716M as Global VC Shifts from Crypto to Enterprise Automation
ViaNews Editorial Team•
venture-capital
Venture Funds Extend to 18-Year Terms as Global Capital Markets Reset
ViaNews Editorial Team•
fintech
Frank Fintech Collapse Exposes $175M Fraud as Investor Lawsuits Mount Globally
ViaNews Editorial Team•
Healthcare & Biotech
Biomerica's Cash Crisis Mirrors Global Biotech Funding Crunch
ViaNews Editorial Team•
